SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-655270
Filing Date
2016-07-22
Accepted
2016-07-22 17:22:02
Documents
4
Period of Report
2016-07-22

Document Format Files

Seq Description Document Type Size
1 6-K d228975d6k.htm 6-K 11083
2 EX-99.1 d228975dex991.htm EX-99.1 7675
3 EX-99.2 d228975dex992.htm EX-99.2 210306
4 GRAPHIC g228975cm_50.jpg GRAPHIC 8696
  Complete submission text file 0001193125-16-655270.txt   242186
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 161780313
SIC: 2834 Pharmaceutical Preparations